Related Experiment Video

Updated: Jul 17, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at

Shi-Ken Sha1, Takuji Sato, Hidetaka Kobayashi

  • 1CanBas Co. Ltd., Makiya Building 5F, 9 Tooriyoko-cho, Numazu 410-0891, Japan.

Molecular Cancer Therapeutics
|January 24, 2007
PubMed

Insights

A novel peptide, CBP501, effectively sensitizes cancer cells to DNA-damaging drugs by abrogating the G(2) checkpoint. This targeted approach enhances chemotherapy efficacy without increasing side effects in normal cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The G(2) checkpoint is crucial for DNA repair, and its abrogation is a promising strategy to enhance cancer therapy.
  • Existing methods for targeting the G(2) checkpoint, such as inhibiting CHK1, have limitations.
  • Identifying effective and selective G(2) checkpoint inhibitors remains a challenge.

Purpose of the Study:

  • To develop and characterize a novel peptide-based G(2) checkpoint inhibitor.
  • To evaluate the efficacy and selectivity of the developed peptide in sensitizing cancer cells to DNA-damaging agents.

Main Methods:

  • Optimization of G(2) checkpoint-abrogating peptides (TAT-S216, TAT-S216A) using a cell cycle phenotype-based protocol.
  • Characterization of the novel peptide CBP501 for its inhibitory activity against CDC25C-phosphorylating molecules.
  • Assessment of CBP501's stability, cellular uptake, and its effect on cancer cell cytotoxicity in combination with DNA-damaging drugs.

Main Results:

  • The optimized peptide CBP501 demonstrated >100-fold increased potency compared to TAT-S216A.
  • CBP501 selectively targets molecules phosphorylating Ser(216) of CDC25C, including CHK1, MAPKAP-K2, and C-Tak1.
  • CBP501 enhanced the cytotoxicity of DNA-damaging anticancer drugs against cancer cells without increasing adverse effects on normal cells.

Conclusions:

  • CBP501 is a potent and selective G(2) checkpoint abrogation drug candidate.
  • The cell cycle phenotype-based protocol is effective for identifying G(2) checkpoint-abrogating compounds.
  • Peptide-based compounds show potential as focused multitarget inhibitors for cancer therapy.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...